Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Gargaro

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Scientific Reports|March 21, 2024
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosisTeresa Zelante, Giuseppe Paolicelli, Francesca Fallarino, et al.
EMBO Reports|November 7, 2020
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1Alberta Iacono, Andrea Pompa, Francesca De Marchis, et al.
Nature|June 17, 2014
Aryl hydrocarbon receptor control of a disease tolerance defence pathwayAlban Bessede, Marco Gargaro, Maria T Pallotta, et al.
NEJM Evidence|February 6, 2024
Liver-Directed Adeno-Associated Virus-Mediated Gene Therapy for Mucopolysaccharidosis Type VINicola Brunetti-Pierri, Rita Ferla, Virginia Maria Ginocchio, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Scientific Reports|March 21, 2024
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosisTeresa Zelante, Giuseppe Paolicelli, Francesca Fallarino, et al.
EMBO Reports|November 7, 2020
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1Alberta Iacono, Andrea Pompa, Francesca De Marchis, et al.
Nature|June 17, 2014
Aryl hydrocarbon receptor control of a disease tolerance defence pathwayAlban Bessede, Marco Gargaro, Maria T Pallotta, et al.
NEJM Evidence|February 6, 2024
Liver-Directed Adeno-Associated Virus-Mediated Gene Therapy for Mucopolysaccharidosis Type VINicola Brunetti-Pierri, Rita Ferla, Virginia Maria Ginocchio, et al.
Pageof 8